Atlas Trials

Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans

Clinical trial NCT03135015 · COMPLETED

Trial details

NCT number
NCT03135015
Sponsor
Housey Healthcare ULC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Insulin Resistance, Diabetes
Start date
2017-04-26
Primary completion
2017-06-21
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.